© Provided by The Motley Fool Black woman using loudspeaker to be heard
It might surprise some investors to know that the FTSE offers exposure to companies operating in the cannabis sector. But while other indexes, namely those in the US, provide greater choice, UK investors in overseas-listed cannabis stocks were recently told they must sell.
This is because of Euroclear, a custodian — or financial trading settlement business, is no longer prepared to support these shares. Those investing through Hargreaves Lansdown and AJ Bell were told they need to sell their overseas holdings by January 27. As such, three of the most sold stocks on the Hargreaves platform last week were North American marijuana companies.
So, what are the options for me as a UK investor now? Let’s take a look.
Types of cannabis stock
Cannabis can be something of a taboo subject. Recreational use has been perceived fairly negatively for some years, but this is a sector that’s creating some interesting opportunities for investors. Increasingly we’re seeing businesses turning to the plant to develop consumer and medical products.
Cannabidiol (or CBD) is legal and has become very popular in Western markets. I’ve followed closely the rise of TRIP, a UK-based, unlisted CBD drinks and oil firm, which has grown phenomenally quickly in recent years. As the founder of a sumac-based drinks company, I’ve been very jealous of its growth!
But what about listed firms rather than privately-held start-ups? Broadly, I can categorise the sector into three parts. There are growers and retailers, pharma and biotechs, and ancillary firms. There’s not a lot of choice out there for me. But it’s growing.
What am I considering?
Associated British Foods is best known for its ownership of Primark, but in 2017 the group signed a deal with GW Pharmaceuticals to supply M250 marijuana — non‐psychoactive cannabis — for drug development purposes.
It’s one of the largest cannabis growers in the UK. It converted 45 acres of tomato greenhouse space to grow hemp plants.
However, it’s certainly worth nothing that investing in Associated British Foods won’t give me much exposure to the sector. After all, it’s only a small part of the firm’s huge portfolio. So I wouldn’t buy this stock just for its cannabis business.
But I’m looking more closely at Futura Medical.
This pharmaceutical group develops cosmetic and pain-relief cannabis medical products. Using its proprietary DermaSys technology, the cannabis-derived ingredients, including CBD, can be turned in a gel and absorbed through the skin.
However, this is an early-stage R&D firm. The MED3000 product for erectile dysfunction was granted a UKCA mark in 2022, meaning it complies with the country’s regulations — but it’s not on sale yet. The company exploring commercialisation opportunities for CBD products but it may be some time before they reach the market.
Obviously firms that are yet to bring a product to market carry greater risk than those already selling, but Futura Medical is one I’m going to be keeping a very close eye on.
In addition to Futura and Associated British Foods, there are several micro-caps, including Kanabo and Cellular Goods. Their development is certainly something I’ll continue watching in this highly promising sector. I’m not a buyer in the sector yet, but I’m tracking it closely.
The post 2 FTSE cannabis stocks I’m considering for the ‘green’ revolution appeared first on The Motley Fool UK.
While the media raves about Google and Amazon, this lesser-known stock has quietly grown 880% – with a:
- Greater than 20X increase in margins
- Nearly 60% compounded revenue growth over 5 years – more than Apple, Amazon and Google!
- A 3,000% earnings explosion
Of course, past performance is no guarantee of future results. However, we think it’s stronger now than ever before. Amazingly, you may never have heard of this company.
Yet there’s a 1-in-3 chance you’ve used one of its 250 brands. Many are household names with millions of monthly website visitors, and that often help consumers compare items, shop around and save.
Now, as the ‘cost of living crisis’ bites, we believe its influence could soar. And that might bring imminent new gains to investors who’re in position today. So please, don’t leave without your FREE report, ‘One Top Growth Stock from The Motley Fool’.
More reading
James Fox has no position in any of the stocks mentioned. The Motley Fool UK has recommended Associated British Foods Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.
Recent Comments